A Phase I Clinical Trial to Evaluate the Safety of Different Immunization Schedules of a Lyophilized Human Rabies Vaccine (Human Diploid Cell)

Clinical trial NCT07338786 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07338786
Sponsor: Changchun BCHT Biotechnology Co.
Status: ENROLLING_BY_INVITATION
Phase: Phase 1
Study type: INTERVENTIONAL

RabiesPrevention

Start date: 2025-09-13
Primary completion: 2026-01-04
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.